alxn1007
mAbexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2011 (NCT01454986)
Timeline
Indications
Mechanism of action
- Complement C5INHIBITOR
C5 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- alxn1007
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02245412 | Phase 2 | Sep 1, 2014 | Alexion |
| NCT02128269 | Phase 2 | Apr 1, 2014 | Alexion |
| NCT01883544 | Phase 1 | Jun 1, 2013 | Alexion |
| NCT01454986 | Phase 1 | Nov 1, 2011 | Alexion |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alexion | For profit | 4 | 4 | 2 | 2011 |
1 organizations
Page 1 / 1